[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Sentiment: XXX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XXX% no change
6 Months: XXX% no change
1 Year: XXX% no change
1-Year High: XXX% on 2024-10-23
1-Year Low: XX% on 2025-07-26
Most Supportive Themes
- Positive Clinical Trial Results: (40%) Multiple posts highlight positive interim Phase II results for ONO-2808 in Multiple System Atrophy (MSA) and ONO-4578 in Gastric or Gastroesophageal Junction Cancer.
- Partnerships and Collaborations: (30%) News of Ono Pharmaceutical's AI-driven research pact with Jorna Therapeutics and deals with LigaChem Biosciences for ADC technology are positively received.
- HER2 CAR-T Cell Therapy: (20%) Mentions of FT825/ONO-8250, a HER2 CAR-T cell therapy co-developed by Fate Therapeutics and ONO PHARMACEUTICAL, in Phase X trials.
Most Critical Themes
- Index Deletion: (10%) MSCI Japan Index is deleting Ono Pharmaceutical Co. from its standard index.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| YouTube | X | X% | XX | XX% | X | X% |
| X | XX | XX% | XX | XX% | X | X% |
| Total | XX | XX% | XX | XX% | X | X% |